1.
Wang CR, Tsai HW. Autoimmune liver diseases in systemicrheumatic diseases. World J Gastroenterol. 2022;28(23):2527-2545.
2.
Teufel A, Weinmann A, Kahaly GJ, et al. Concurrent autoimmunediseases in patients with autoimmune hepatitis. J ClinGastroenterol. 2010;44(3):208-213.
3.
Wong GW, Yeong T, Lawrence D, Yeoman AD, Verma S, HeneghanMA. Concurrent extrahepatic autoimmunity in autoimmunehepatitis: implications for diagnosis, clinical course and long-term outcomes. Liver Int. 2017;37(3):449-457.
4.
Floreani A, Franceschet I, Cazzagon N, et al. Extrahepaticautoimmune conditions associated with primary biliary cirrhosis.Clin Rev Allergy Immunol. 2015;48(2-3):192-197.
5.
Silveira MG, Mendes FD, Diehl NN, Enders FT, Lindor KD.Thyroid dysfunction in primary biliary cirrhosis, primarysclerosing cholangitis and non-alcoholic fatty liver disease. LiverInt. 2009;29(7):1094-1100.
6.
Choudhuri G, Somani SK, Baba CS, Alexander G. Autoimmunehepatitis in India: profile of an uncommon disease. BMCGastroenterol. 2005;5:27.
7.
Ralli M, Angeletti D, Fiore M, et al. Hashimoto's thyroiditis:An update on pathogenic mechanisms, diagnostic protocols,therapeutic strategies, and potential malignant transformation.Autoimmun Rev. 2020;19(10):102649.
8.
Muratori P, Fabbri A, Lalanne C, Lenzi M, Muratori L. Autoimmuneliver disease and concomitant extrahepatic autoimmune disease.Eur J Gastroenterol Hepatol. 2015;27(10):1175-1179.
9.
Zeng Q, Zhao L, Wang C, et al. Relationship between autoimmuneliver disease and autoimmune thyroid disease: a cross-sectionalstudy. Scand J Gastroenterol. 2020;55(2):216-221.
10.
Khoury T, Kadah A, Mari A, Sbeit W, Drori A, Mahamid M.Thyroid dysfunction is prevalent in autoimmune hepatitis: a casecontrol study. Isr Med Assoc J. 2020;22(2):100-103.
11.
Castagna MG, Belardini V, Memmo S, et al. Nodules in autoimmunethyroiditis are associated with increased risk of thyroid cancer insurgical series but not in cytological series: evidence for selectionbias. J Clin Endocrinol Metab. 2014;99(9):3193-3198.
12.
Tansel A, Katz LH, El-Serag HB, et al. Incidence and determinantsof hepatocellular carcinoma in autoimmune hepatitis: asystematic review and meta-analysis. Clin Gastroenterol Hepatol.2017;15(8):1207-1217.
13.
Sharma R, Verna EC, Simon TG, et al. Cancer risk in patients withautoimmune hepatitis: a nationwide population-based cohortstudy with histopathology. Am J Epidemiol. 2022;191(2):298-319.
14.
Werner M, Almer S, Prytz H, et al. Hepatic and extrahepaticmalignancies in autoimmune hepatitis. A long-term follow-up in473 Swedish patients. J Hepatol. 2009;50(2):388-393.
15.
Wang KK, Czaja AJ, Beaver SJ, Go VL. Extrahepatic malignancyfollowing long-term immunosuppressive therapy of severehepatitis B surface antigen-negative chronic active hepatitis.Hepatology. 1989;10(1):39-43.
16.
Ott RA, Calandra DB, McCall A, Shah KH, Lawrence AM,Paloyan E. The incidence of thyroid carcinoma in patients withHashimoto's thyroiditis and solitary cold nodules. Surgery.1985;98(6):1202-1206.
17.
Boi F, Lai ML, Marziani B, Minerba L, Faa G, Mariotti S. Highprevalence of suspicious cytology in thyroid nodules associated withpositive thyroid autoantibodies. Eur J Endocrinol. 2005;153(5):637-642.
18.
Floreani A, Mangini C, Reig A, et al. Thyroid Dysfunctionin Primary Biliary Cholangitis: A Comparative Study at TwoEuropean Centers. Am J Gastroenterol. 2017;112(1):114-119.
19.
Fisher SB, Perrier ND. The incidental thyroid nodule. CA CancerJ Clin. 2018;68(2):97-105.
20.
McQueen AS, Bhatia KS. Thyroid nodule ultrasound: technicaladvances and future horizons. Insights Imaging. 2015;6(2):173-188.